You searched for: plasmareninaktivitet (Danska - Engelska)

der er sjældent konstateret forhøjet plasmareninaktivitet og takykardi ved langvarig behandling.
increase in plasma renin activity and tachycardia have rarely been seen during long-term treatment.

at1-receptoren blev også blokeret, vist ved øget plasmareninaktivitet og øgede plasmareninkoncentrationer.
the at1-receptor was also blocked as evidenced by increased plasma renin activity and plasma renin concentrations.

den blodtrykssænkende effekt ledsages af en let øgning af filtrationsfraktionen, den renale vaskulære modstand og plasmareninaktivitet.
the blood-pressure-lowering effect is accompanied by slight increases in the filtration fraction, renal vascular resistance and plasma renin activity.

i rotter og hunde blev der observeret forhøjet plasmareninaktivitet og hypertrofi/hyperplasi af de juxtaglomerulære nyreceller.
in rats and dogs, increased plasma renin activity and hypertrophy/hyperplasia of the renal juxtaglomerular cells were observed.

hos begge arter blev der observeret forøget plasmareninaktivitet og hypertrofi/hyperplasi af de renale juxtaglomerulære celler.
in both species, increased plasma renin activity and hypertrophy/hyperplasia of the renal juxtaglomerular cells were observed.

under administration af losartan fører fjernelse af angiotensin- ii’ s negative feedback på reninsekretionen til øget plasmareninaktivitet (pra).
during the administration of losartan the removal of the angiotensin ii negative feedback on renin secretion leads to increased plasma-renin activity (pra).

hæmning af ace resulterer i en reduktion af angiotensin ii i plasmaet, som bevirker en øget plasmareninaktivitet (ved hæmning af den negative feedback fra reninfrigørelse) og reduceret sekretion af aldosteron.
inhibition of ace results in a reduction of angiotensin ii in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone.

under administration af losartan leder fjernelse af angiotensin- ii’ s negative feed- back på reninsekretionen til øget plasmareninaktivitet (pra).
33 during administration of losartan, removal of the angiotensin ii negative feedback on renin secretion leads to increased plasma renin activity (pra).

toksikologiske fund, som også er kendt fra prækliniske forsøg med " angiotensin converting enzyme " -hæmmere og angiotensin ii-receptor-antagonister, var:reducerede røde blodcelleparametre (erytrocytter, hæmoglobin, hæmatokrit) , ændringer i den renale hæmodynamik (forhøjet bun og kreatinin) , forøget plasmareninaktivitet, hypertrofi/hyperplasi af de juxtaglomerulære celler og gastriske slimhindelæsioner.
toxicological findings also well known from preclinical studies with angiotensin converting enzyme inhibitors and angiotensin ii receptor antagonists were: a reduction of red cell parameters (erythrocytes, haemoglobin, haematocrit) , changes of renal haemodynamics (increased blood urea nitrogen and creatinine) , increased plasma renin activity, hypertrophy/hyperplasia of the juxtaglomerular cells and gastric mucosal injury.